| 113.1 -3.18 (-2.73%) | 12-01 00:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Brooks Automation, Inc. (BRKS), founded in 1978 and headquartered in Chelmsford, Massachusetts, stands as a global leader in delivering advanced automation and cryogenic technologies to clients in approximately 50 countries. The company operates through two distinct divisions: the Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group is dedicated to the semiconductor capital equipment sector, offering sophisticated wafer automation and contamination control solutions alongside a full suite of support services. This segment's product range encompasses a variety of atmospheric and vacuum robots, robotic modules, and comprehensive tool automation systems, all designed to ensure precise handling and maintain pristine conditions within wafer environments. They also provide automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. Beyond products, this group offers crucial services including repairs, diagnostics, installations, spare parts, and productivity-boosting upgrades. The Brooks Life Science Systems division caters to the intricate demands of the life sciences sample management market. It supplies automated cold storage systems and an extensive array of consumables, such as various formats of racks, tubes, caps, plates, and foils. Additionally, the segment manufactures specialized instruments for laboratory tasks like labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. Its comprehensive service offerings span complete sample management, including both on-site and off-site storage, meticulous cold chain logistics, secure sample transport and relocation, bio-processing solutions, disaster recovery, and business continuity planning, complemented by expert project management and consulting. This division further develops advanced sample intelligence software, facilitates customer technology integration, and provides solutions for optimizing laboratory workflow scheduling, managing sample inventory and logistics, monitoring environmental conditions, overseeing clinical trials and consent, as well as offering planning, data management, virtualization, and visualization services. Moreover, it delivers gene sequencing analysis and synthesis capabilities.
Thu, 07 Oct 2021
Brooks Automation Announces Transition and Departure Plans of Dr. Amy Liao - citybiz
Fri, 24 Sep 2021
Mintz Represents Brooks Automation in $3B Sale of Semiconductor Solutions Business to Thomas H. Lee Partners - Mintz
Mon, 10 May 2021
Brooks Automation Splits in Two to Serve Chip, Drug Clients - Bloomberg
Mon, 26 Apr 2021
Brooks To Acquire Precise Automation - citybiz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Semiconductors
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|